286932-39-6

Basic information

• Product Name: 5-Bromo-N-tert-butyl-2-thiophenesulfonamide
• Synonyms: N-tert-Butyl-5-bromothiophene sulfonamide;5-Bromo-N-tert-butyl-2-thiophenesulfonamide;N-tert-Butyl-5-bromothiophene-2-sulfonamide;5-Bromo-N-(tert-butyl)thiophene-2-sulphonamide;N-tert-Butyl 5-Bromo-2-thiophenesulfonamide;5-broMo-N-tert-butylthiophene-2-sulfonaMide;N-tert-Butyl 5-BroMo-2-thiophenesulfonaMide;N-tert-Butyl 5-Bromo-2-thiophenesulfonamide
• CAS NO: 286932-39-6
• Molecular Formula: C8H12BrNO2S2
• Molecular Weight: 298.22
• EINECS: 214-402-0
• Product Categories: Thiophene intermediates
• Mol File: 286932-39-6.mol

Chemical Properties

• Melting Point: 62℃
• Boiling Point: 366.1 °C at 760 mmHg
• Flash Point: 175.2 °C
• Appearance: /
• Density: 1.527
• Vapor Pressure: 1.5E-05mmHg at 25°C
• Refractive Index: 1.565
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 11.53±0.50(Predicted)
• CAS DataBase Reference: 5-Bromo-N-tert-butyl-2-thiophenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-N-tert-butyl-2-thiophenesulfonamide(286932-39-6)
• EPA Substance Registry System: 5-Bromo-N-tert-butyl-2-thiophenesulfonamide(286932-39-6)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 286932-39-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-N-tert-butyl-2-thiophenesulfonamide is used as a pharmaceutical intermediate for the development of new drugs. Its unique structure, including the bromine and tert-butyl groups, may contribute to the creation of novel therapeutic agents with specific pharmacological properties.
Used in Organic Chemistry:
In the realm of organic chemistry, 5-Bromo-N-tert-butyl-2-thiophenesulfonamide serves as a key building block in the synthesis of other organic compounds. Its presence in various chemical reactions can lead to the formation of new molecules with potential applications in different industries, including pharmaceuticals, materials science, and agrochemicals.
As research progresses, it is expected that the uses of 5-Bromo-N-tert-butyl-2-thiophenesulfonamide will expand, potentially encompassing a wider range of applications across various fields. Its current and future applications underscore the importance of continued investigation into its properties and potential benefits.

InChI:InChI=1/C8H12BrNO2S2/c1-8(2,3)10-14(11,12)7-5-4-6(9)13-7/h4-5,10H,1-3H3

Upstream product

• 55854-46-1 5-bromo-2-thiophenesulfonyl chloride 
• 75-64-9 tert-butylamine 

Downstream Products

• 53595-65-6 5-bromo-thiophene-2-sulfonamide 
• 951233-59-3 N-(tert-butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-sulfonamide 
• 912962-74-4 3-(3-((1H-imidazol-1-yl)methyl)phenyl)-N-(tert-butyl)-5-isobutylthiophene-2-sulfonamide 
• 146013-28-7 N-(tert-butyl)-5-isobutylthiophene-2-sulphonamide 

Relevant articles and documents

Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design to Minimize Host Kinase Interactions

Drug resistant tuberculosis (TB) infections are on the rise and antibiotics that inhibit Mycobacterium tuberculosis through a novel mechanism could be an important component of evolving TB therapy. Protein kinase A (PknA) and protein kinase B (PknB) are both essential serine-threonine kinases in M. tuberculosis. Given the extensive knowledge base in kinase inhibition, these enzymes present an interesting opportunity for antimycobacterial drug discovery. This study focused on targeting both PknA and PknB while improving the selectivity window over related mammalian kinases. Compounds achieved potent inhibition (Ki ≈ 5 nM) of both PknA and PknB. A binding pocket unique to mycobacterial kinases was identified. Substitutions that filled this pocket resulted in a 100-fold differential against a broad selection of mammalian kinases. Reducing lipophilicity improved antimycobacterial activity with the most potent compounds achieving minimum inhibitory concentrations ranging from 3 to 5 μM (1-2 μg/mL) against the H37Ra isolate of M. tuberculosis.

A convergent synthesis of AR-C123196 utilising reaction between a cyclic carbonate and a phenol for aryl alkyl ether formation

The development of a convergent synthesis of AR-C123196 is reported in which the alkyl aryl ether linkage was formed by nucleophilic attack of a phenolic hydroxyl group onto a cyclic carbonate. This approach was successfully operated on a multikilogram sc